Literature DB >> 14982772

In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis.

Alejandra Gomez-Flores1, Oliverio Welsh, Salvador Said-Fernández, Gerardo Lozano-Garza, Roman Erick Tavarez-Alejandro, Lucio Vera-Cabrera.   

Abstract

In Mexico mycetomas are mostly produced by Nocardia brasiliensis, which can be isolated from about 86% of cases. In the present work, we determined the sensitivities of 30 N. brasiliensis strains isolated from patients with mycetoma to several groups of antimicrobials. As a first screening step we carried out disk diffusion assays with 44 antimicrobials, including aminoglycosides, cephalosporins, penicillins, quinolones, macrolides, and some others. In these assays we observed that some antimicrobials have an effect on more than 66% of the strains: linezolid, amikacin, gentamicin, isepamicin, netilmicin, tobramycin, minocycline, amoxicillin-clavulanic acid, piperacillin-tazobactam, nitroxolin, and spiramycin. Drug activity was confirmed quantitatively by the broth microdilution method. Amoxicillin-clavulanic acid, linezolid, and amikacin, which have been used to treat patients, were tested in an experimental model of mycetoma in BALB/c mice in order to validate the in vitro results. Linezolid showed the highest activity in vivo, followed by the combination amoxicillin-clavulanic acid and amikacin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14982772      PMCID: PMC353153          DOI: 10.1128/AAC.48.3.832-837.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Lymphocutaneous Nocardia brasiliensis infection: a pediatric case cured with amoxicilin/clavulanate.

Authors:  D Nolt; R M Wadowsky; M Green
Journal:  Pediatr Infect Dis J       Date:  2000-10       Impact factor: 2.129

2.  [Action of diaminodiphenylsulfone on Nocardia brasiliensis; studies in vitro, in experimental infection and in the clinic].

Authors:  A GONZALEZ OCHOA; J SHIELS; P VAZQUEZ
Journal:  Gac Med Mex       Date:  1952 Sep-Oct       Impact factor: 0.302

Review 3.  Mycetoma. Current concepts in treatment.

Authors:  O Welsh
Journal:  Int J Dermatol       Date:  1991-06       Impact factor: 2.736

4.  Medical management of mycetoma.

Authors:  E S Mahgoub
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

5.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 6.  [Oxazolidinones and glycopeptides].

Authors:  Carlos Pigrau
Journal:  Enferm Infecc Microbiol Clin       Date:  2003-03       Impact factor: 1.731

7.  Clinical experience with linezolid for the treatment of nocardia infection.

Authors:  Edina H Moylett; Susan E Pacheco; Barbara A Brown-Elliott; Tracy R Perry; E Stephen Buescher; Mary C Birmingham; Jerome J Schentag; Joseph F Gimbel; Aaron Apodaca; Margot A Schwartz; Robert M Rakita; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-01-13       Impact factor: 9.079

8.  Identification of nocardiae and streptomycetes of medical importance.

Authors:  S K Mishra; R E Gordon; D A Barnett
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

9.  Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.

Authors:  R J Wallace; D R Nash; W K Johnson; L C Steele; V A Steingrube
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

Review 10.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

View more
  18 in total

1.  In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Adrian Rendon; Jorge Ocampo-Candiani; Oliverio Welsh; Victor M Velazquez-Moreno; Sung Hak Choi; Carmen Molina-Torres
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Successful treatment of a disseminated Nocardia brasiliensis infection.

Authors:  L C Smeets; M A van Agtmael; E R van der Vorm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

3.  Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.

Authors:  Patricia S Conville; Barbara A Brown-Elliott; Richard J Wallace; Frank G Witebsky; Deloris Koziol; Geraldine S Hall; Scott B Killian; Cindy C Knapp; David Warshauer; Tam Van; Nancy L Wengenack; Sharon Deml; Gail L Woods
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

4.  In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Authors:  Emilia Cercenado; Mercedes Marín; Mónica Sánchez-Martínez; Oscar Cuevas; José Martínez-Alarcón; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

5.  Disseminated nocardiosis caused by Nocardia otitidiscaviarum in an immunocompetent host: A case report and literature review.

Authors:  Yanwen Jiang; Aiben Huang; Qiuhong Fang
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

6.  In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.

Authors:  Alejandra Daw-Garza; Oliverio Welsh; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

7.  Central venous catheter-associated Nocardia bacteremia in cancer patients.

Authors:  Fadi Al Akhrass; Ray Hachem; Jamal A Mohamed; Jeffrey Tarrand; Dimitrios P Kontoyiannis; Jyotsna Chandra; Mahmoud Ghannoum; Souha Haydoura; Ann Marie Chaftari; Issam Raad
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

8.  Complete genome sequence analysis of Nocardia brasiliensis HUJEG-1 reveals a saprobic lifestyle and the genes needed for human pathogenesis.

Authors:  Lucio Vera-Cabrera; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Jorge Ocampo-Candiani
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

Review 9.  Nocardiosis in transplant recipients.

Authors:  D Lebeaux; E Morelon; F Suarez; F Lanternier; A Scemla; P Frange; J-L Mainardi; M Lecuit; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-23       Impact factor: 5.103

10.  Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Alejandra Daw-Garza; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Sung-Hak Choi; Oliverio Welsh
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.